Results 1 to 10 of about 3,735,339 (297)
The challenges of difficult-to-treat <i>Acinetobacter</i> infections. [PDF]
Clin Microbiol RevSUMMARY Infections due to Acinetobacter spp. are among the most difficult to treat. Most are resistant to standard antibiotics, and there is difficulty in distinguishing colonizers from pathogens. This mini-review examines the available antibiotics that exhibit activity against these organisms and provides
Richards GA, Perovic O, Brink AJ.
europepmc +4 more sources
An Update on the arsenal for multidrug-resistant Acinetobacter infections: Polymyxin antibiotics
International Journal of Infectious Diseases, 2015 OBJECTIVE To review recent clinical pharmacokinetic and pharmacodynamic data to optimize dosing regimens for polymyxin B and colistin for treatment of infections due to A. baumannii.
Zahra Kassamali +2 more
exaly +2 more sources
Managing Acinetobacter baumannii infections
Current Opinion in Infectious Diseases, 2019 Purpose of review We reviewed recent data about epidemiology of Acinetobacter baumannii, resistance mechanisms, and therapeutic options for severe infections caused by multidrug-resistant strains. Recent findings A.
Garnacho-Montero, José +1 more
openaire +4 more sources
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges [PDF]
Clinical Microbiology Reviews, 2017 Darren Wong +2 more
exaly +2 more sources
Metagenomic sequencing diagnosed the acinetobacter gyllenbergii ventriculitis: one case report
Chinese Journal of Contemporary Neurology and Neurosurgery, 2021 doi：10.3969/j.issn.1672⁃6731.2021.12 ...
WANG Di +5 more
doaj +1 more source
A Comparative Study of Acinetobacter Infections in COVID and Non-COVID Patients
Journal of Infectious Diseases and Epidemiology, 2022 Background: Acinetobacter species are associated with high mortality, A. baumannii being associated with a significant number of Hospital acquired infections worldwide. Multidrug resistance makes it challenging to control or treat these infections.
Syed Rayeesa Faheem +2 more
semanticscholar +1 more source
A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
Clinical Infectious Diseases, 2014 David J Ritchie
exaly +2 more sources
Acinetobacter baumannii in the critically ill: complex infections get complicated
Frontiers in Microbiology, 2023 Acinetobacter baumannii is increasingly associated with various epidemics, representing a serious concern due to the broad level of antimicrobial resistance and clinical manifestations. During the last decades, A.
Ilaria Cavallo +8 more
semanticscholar +1 more source
Journal of Infection and Public Health, 2023 BACKGROUND Acinetobacter baumannii infection is a serious public health problem because it is highly resistant to antimicrobial therapy and causes a high fatality rate in critically ill patients.
Taghreed A Hafiz +6 more
semanticscholar +1 more source